BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34382383)

  • 1. Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma.
    Bastidas Torres AN; Melchers RC; Van Grieken L; Out-Luiting JJ; Mei H; Agaser C; Kuipers TB; Quint KD; Willemze R; Vermeer MH; Tensen CP
    Haematologica; 2022 Jul; 107(7):1619-1632. PubMed ID: 34382383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
    Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
    J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma--is it a new variant?
    Kumaran MS; Jithendriya M; Nagaraj P; Tirumalae R; Jayaseelan E
    Indian J Dermatol Venereol Leprol; 2012; 78(3):354-7. PubMed ID: 22565437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatially Resolved Transcriptomes of CD30+-Transformed Mycosis Fungoides and Cutaneous Anaplastic Large-Cell Lymphoma.
    Choi ME; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
    J Invest Dermatol; 2024 Feb; 144(2):331-340.e2. PubMed ID: 37544586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
    Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
    Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) in the Elderly and the Importance of Sport Activity Training.
    Sica A; Vitiello P; Ronchi A; Casale B; Calogero A; Sagnelli E; Costa Nachtigal G; Troiani T; Franco R; Argenziano G; Moscarella E; Sagnelli C
    Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32013101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
    Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
    Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL.
    Plaza JA; Ortega P; Lynott J; Mullane M; Kroft S; Olteanu H
    Am J Dermatopathol; 2010 Jul; 32(5):489-91. PubMed ID: 20442639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review.
    Di Raimondo C; Parekh V; Song JY; Rosen ST; Querfeld C; Zain J; Martinez XU; Abdulla FR
    Curr Hematol Malig Rep; 2020 Aug; 15(4):333-342. PubMed ID: 32435988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
    Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.
    Velusamy T; Kiel MJ; Sahasrabuddhe AA; Rolland D; Dixon CA; Bailey NG; Betz BL; Brown NA; Hristov AC; Wilcox RA; Miranda RN; Medeiros LJ; Jeon YK; Inamdar KV; Lim MS; Elenitoba-Johnson KS
    Blood; 2014 Dec; 124(25):3768-71. PubMed ID: 25349176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30
    Sauder MB; O'Malley JT; LeBoeuf NR
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):317-334. PubMed ID: 28340881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
    Sanka RK; Eagle RC; Wojno TH; Neufeld KR; Grossniklaus HE
    Ophthalmology; 2010 Feb; 117(2):343-51. PubMed ID: 19969358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule.
    Xue D; Li X; Ren Y; Liu Q; Yen Y; Xue L
    Int J Surg Pathol; 2015 Jun; 23(4):333-5. PubMed ID: 25633507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of primary cutaneous anaplastic large cell lymphoma with prominent epidermotropism.
    Miyagaki T; Sugaya M; Miyamoto A; Tamaki K; Ota S; Sato S
    Int J Hematol; 2012 Jun; 95(6):711-5. PubMed ID: 22450880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS; Hardman DL; Boni R; Dummer R; Kim YH; Smoller BR; Takeshita M; Kikuchi M; Burg G
    Blood; 1996 Sep; 88(5):1765-70. PubMed ID: 8781433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides.
    Mitteldorf C; Robson A; Tronnier M; Pfaltz MC; Kempf W
    Dermatology; 2015; 231(2):164-70. PubMed ID: 26111483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary cutaneous anaplastic CD30+ large cell lymphoma].
    Marrero-Calvo MD; Rodríguez-Serna M; Castejón-Calvete P; Peláez-Malagón S
    Actas Dermosifiliogr; 2007 Apr; 98(3):194-7. PubMed ID: 17504705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
    Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF
    Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.